Piramal Pharma's US facility clears FDA inspection
Piramal Pharma's US facility clears FDA inspection. Piramal Pharma Limited announced the successful closure of a US FDA inspection at its Sellersville, USA manufacturing facility. This confirms compliance with regulatory standards and reduces risk of supply disruptions. The outcome supports operational credibility and potential export scalability.
📊 STOCKS: PPL | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #FDA
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.